Spironolactone Tablet, Film Coated
Product Images NDC 43063-835

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 43063-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063835 Label (43063835)

This is a description of a medicine called Spironolactone, which comes in the form of tablets. Each tablet contains 100mg of the active ingredient and is film-coated. The package contains 30 tablets with a Lot number of c22883 and an expiration date of December 2023. There is a phone number to call for advice about side effects or to report them to the FDA. The instruction is to take the tablet(s) a few times a day, and the pharmaceutical company is located in Oklahoma City. There are also several identifying codes and markings on the package.*

FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)

This text is not enough to generate a useful description. It appears to be a partial output from a statistical analysis report, with some missing characters and incomplete data.*

FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)

FDA Label Image

Chemical Structure (Spironolactone Structure Image)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.